Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Ainos, Inc. - Common Stock
Allarity Therapeutics, Inc. - Common stock
Alpha and Omega Semiconductor Limited - Common Shares
AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares
Brag House Holdings, Inc. - Common Stock
Capstone Copper Corp
Champion Real Estate Investment Trust
Clifton Mining Co.
DEFSEC Technologies Inc. - common stock, no R/S concurrent with offering
Danaos Corporation
Farmers & Merchants Bancorp
First Reliance Bncshs Inc
Fosun Intl Ltd ADR
Founder Group Limited - Class A Ordinary Shares
Hamilton Global Financials ETF
Hannover Re Se ADR
Innovation Pharmaceuticals Inc
Jx Holdings Inc Ord
Marker Therapeutics, Inc. - Common Stock
Maui Land & Pineapple Company, Inc. Common Stock
Mitsubishi Motors
Mowi ASA ADR
Organto Foods Inc
Ping An Ins CO of China
Ready Capital Corporation Common Stock
Resona Holdings Inc
Robinhood Markets, Inc. - Class A Common Stock
SOC Telemed, Inc. - Class A Common Stock
Silence Therapeutics Plc - American Depository Share
Snail, Inc. - Class A Common Stock
Steelcase Inc. Common Stock
Strategic Metals Ltd New
Synaptogenix, Inc. - Common Stock
Take-Two Interactive Software, Inc. - Common Stock
Timberline Resources Corp
Unity Wealth Partners Dynamic Capital Appreciation & Options ETF
WisdomTree U.S. SmallCap Fund
iRhythm Holdings, Inc. - Common Stock
iShares U.S. Technology ETF
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
BioStem Technologies, Inc. - Common Stock
(NQ:
BSEM
)
1.510
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BioStem Technologies, Inc. - Common Stock
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue Deal
↗
August 21, 2026
BioStem Technologies (OTCMKTS:BSEM) outlined its strategy to expand in surgical applications, shift its revenue mix away from physician-office wound care and bring manufacturing of acquired products...
Via
MarketBeat
BioStem Technologies Q2 Earnings Call Highlights
↗
August 13, 2026
BioStem Technologies (OTCMKTS:BSEM) reported second-quarter revenue of $7.9 million as the company continued its transition to a predominantly hospital-focused commercial model. Revenue increased from...
Via
MarketBeat
Topics
Earnings
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.